Search

NMR solution structure of lysostaphin
Authors
Tossavainen, H., Raulinaitis, V., Permi, P.
Assembly
Lysostaphin (E.C.3.4.24.75)
Entity
1. Lysostaphin (E.C.3.4.24.75), entity 1 (polymer, Thiol state: not present), 245 monomers, 26844.78 Da Detail

GSHEHSAQWL NNYKKGYGYG PYPLGINGGM HYGVDFFMNI GTPVKAISSG KIVEAGWSNY GGGNQIGLIE NDGVHRQWYM HLSKYNVKVG DYVKAGQIIG WSGSTGYSTA PHLHFQRMVN SFSNSTAQDP MPFLKSAGYG KAGGTVTPTP NTGWKTNKYG TLYKSESASF TPNTDIITRT TGPFRSMPQS GVLKAGQTIH YDEVMKQDGH VWVGYTGNSG QRIYLPVRTW NKSTNTLGVL WGTIK


2. Lysostaphin (E.C.3.4.24.75), entity ZN (non-polymer), 65.409 Da
Total weight
26910.188 Da
Max. entity weight
26844.78 Da
Source organism
Staphylococcus simulans
Exptl. method
solution NMR
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 98.8 %, Completeness: 88.3 %, Completeness (bb): 84.5 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All88.3 % (2481 of 2810)95.9 % (1391 of 1451)76.9 % (840 of 1092)93.6 % (250 of 267)
Backbone84.5 % (1222 of 1446)95.1 % (489 of 514)73.5 % (514 of 699)94.0 % (219 of 233)
Sidechain92.4 % (1453 of 1573)95.7 % (897 of 937)87.4 % (526 of 602)88.2 % (30 of 34)
Aromatic80.6 % (266 of 330)96.4 % (159 of 165)63.1 % (99 of 157)100.0 % (8 of 8)
Methyl96.8 % (211 of 218)97.2 % (106 of 109)96.3 % (105 of 109)

1. entity 1

GSHEHSAQWL NNYKKGYGYG PYPLGINGGM HYGVDFFMNI GTPVKAISSG KIVEAGWSNY GGGNQIGLIE NDGVHRQWYM HLSKYNVKVG DYVKAGQIIG WSGSTGYSTA PHLHFQRMVN SFSNSTAQDP MPFLKSAGYG KAGGTVTPTP NTGWKTNKYG TLYKSESASF TPNTDIITRT TGPFRSMPQS GVLKAGQTIH YDEVMKQDGH VWVGYTGNSG QRIYLPVRTW NKSTNTLGVL WGTIK

Sample #1

Solvent system 93% H2O/7% D2O, Pressure 1 atm, Temperature 308 K, pH 6.5, Details 0.36 mM [U-13C; U-15N] lysostaphin, 20 mM Bis-Tris, 0.36 mM ZnCl2, 93% H2O/7% D2O


#NameIsotope labelingTypeConcentration
1lysostaphin[U-13C; U-15N]0.36 mM
2Bis-Trisnatural abundance20 mM
3ZnCl2natural abundance0.36 mM
Sample #2

Solvent system 100% D2O, Pressure 1 atm, Temperature 308 K, pH 6.5, Details 0.47 mM [U-13C; U-15N] lysostaphin, 20 mM Bis-Tris, 0.36 mM ZnCl2, 100% D2O


#NameIsotope labelingTypeConcentration
4lysostaphin[U-13C; U-15N]0.47 mM
5Bis-Trisnatural abundance20 mM
6ZnCl2natural abundance0.36 mM

LACS Plot; CA
Referencing offset: -1.4 ppm, Outliers: 1 Detail
LACS Plot; CB
Referencing offset: -1.4 ppm, Outliers: 1 Detail
LACS Plot; HA
Referencing offset: -0.06 ppm, Outliers: 1 Detail
Release date
2017-04-10
Citation
Structural and Functional Insights Into Lysostaphin-Substrate Interaction
Tossavainen, H., Raulinaitis, V., Kauppinen, L., Pentikainen, U., Maaheimo, H., Permi, P.
Front. Mol. Biosci. (2018), 5, 60-60, PubMed 30018958 , DOI 10.3389/fmolb.2018.00060 ,
Related entities 1. Lysostaphin (E.C.3.4.24.75), entity 1, : 1 : 5 entities Detail
Experiments performed 14 experiments Detail
NMR combined restraints 6 contents Detail
Keywords M23, bacterial SH3, hydrolase, peptidase, peptidoglycan